| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |